CHARLES J. DOCKENDORFF

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BOSTON SCIENTIFIC CORP

Filing Date Source Excerpt
2020-03-25 Education: University of Massachusetts at Amherst, B.B.A. in Accounting; Bentley College, M.S. in Finance
2021-03-24 Education: University of Massachusetts at Amherst, B.B.A. in Accounting; Bentley College, M.S. in Finance
2022-03-23 EDUCATION: University of Massachusetts at Amherst, B.B.A. in Accounting; Bentley College, M.S. in Finance
2023-03-22 Mr. Dockendorff is the former Executive Vice President and Chief Financial Officer of Covidien plc... While Chief Financial Officer of Covidien plc, Mr. Dockendorff was also in charge of Information Security for the company.
2024-03-20 Mr. Dockendorff is the former Executive Vice President and Chief Financial Officer of Covidien plc... While Chief Financial Officer of Covidien plc, Mr. Dockendorff was also in charge of Information Security for the company. ... Mr. Dockendorff’s qualifications to serve on our Board include his executive leadership experience at public medical device companies, his service as a director of other public companies, as well as his extensive expertise in accounting, finance, technology and business strategy.

HAEMONETICS CORP

Filing Date Source Excerpt
2014-06-13 Mr. Dockendorff, 59, is currently Executive Vice President and Chief Financial Officer (CFO) of Covidien plc, a leading $10 billion global healthcare products company.
2015-06-11 Mr. Dockendorff, 60, joined the Board of Directors in 2014 and is Chairman of the Audit Committee.
2016-06-10 Mr. Dockendorff, 61, joined the Board of Directors in 2014 and is Chairman of the Audit Committee.
2017-06-12 Charles J. Dockendorff, 62, joined the Board of Directors in 2014 and is Chairman of the Audit Committee. He currently serves as a member of the Board of Directors of Boston Scientific Corporation, where he is currently Chairman of the Audit Committee and member of the Finance Committee, Hologic, Inc., where he serves as a member of the Audit Committee, and Keysight Technologies Inc., where he is Chairman of the Audit and Finance Committee and a member of the Nominating and Corporate Governance Committee. Compensation for the Board of Directors in fiscal 2017 was $258,477 for Mr. Dockendorff.
2018-06-12 Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc Age: 63 Mr. Dockendorff joined our Board in 2014 and is Chairman of the Audit Committee. DIRECTOR COMPENSATION TABLE FOR FISCAL YEAR ENDED MARCH 31, 2018 Charles J. Dockendorff Fees Earned or Paid in Cash ($): 97,000 Stock Awards ($): 170,000 Total ($): 267,000
2019-06-12 Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc. Age: 64. Mr. Dockendorff joined our Board in 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Director Compensation Table for Fiscal Year Ended March 30, 2019 shows total compensation of $266,939.
2020-06-08 Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc Age: 65 Mr. Dockendorff joined our Board in 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Mr. Dockendorff served as Executive Vice President and Chief Financial Officer of Covidien plc, a global healthcare company, and its predecessor, Tyco Healthcare, from 1995 until his retirement in 2015. Mr. Dockendorff joined the Kendall Healthcare Products Company, the foundation of the Tyco Healthcare business, in 1989 as Controller and was named Vice President and Controller five years later. Prior to joining Kendall/Tyco Healthcare, Mr. Dockendorff was the Chief Financial Officer, Vice President of Finance and Treasurer of Epsco, Inc. and Infrared Industries, Inc. Earlier in his career, Mr. Dockendorff worked as an accountant for Arthur Young & Company (now Ernst & Young LLP) and the General Motors Corporation.
2021-06-17 Mr. Dockendorff joined our Board in 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Mr. Dockendorff served as Executive Vice President and Chief Financial Officer of Covidien plc, a global healthcare company, and its predecessor, Tyco Healthcare, from 1995 until his retirement in 2015. Mr. Dockendorff joined the Kendall Healthcare Products Company, the foundation of the Tyco Healthcare business, in 1989 as Controller and was named Vice President and Controller five years later. Prior to joining Kendall/Tyco Healthcare, Mr. Dockendorff was the Chief Financial Officer, Vice President of Finance and Treasurer of Epsco, Inc. and Infrared Industries, Inc. Earlier in his career, Mr. Dockendorff worked as an accountant for Arthur Young & Company (now Ernst & Young LLP) and the General Motors Corporation.
2022-06-17 Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc Age: 67 Mr. Dockendorff joined our Board in July 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Mr. Dockendorff served as Executive Vice President and Chief Financial Officer of Covidien plc, a global healthcare company, and its predecessor, Tyco Healthcare, from 1995 until his retirement in 2015. Mr. Dockendorff joined the Kendall Healthcare Products Company, the foundation of the Tyco Healthcare business, in 1989 as Controller and was named Vice President and Controller five years later. Prior to joining Kendall/Tyco Healthcare, Mr. Dockendorff was the Chief Financial Officer, Vice President of Finance and Treasurer of Epsco, Inc. and Infrared Industries, Inc. Earlier in his career, Mr. Dockendorff worked as an accountant for Arthur Young & Company (now Ernst & Young LLP) and the General Motors Corporation.
2023-06-16 Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc Age: 68 Mr. Dockendorff joined our Board in July 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Director Compensation Table for Fiscal Year Ended April 1, 2023 Charles J. Dockendorff Fees Earned or Paid in Cash: $103,000 Stock Awards: $189,953 Total: $292,953
2024-06-07 Retired Executive Vice President and Chief Financial Officer, Covidien plc

HOLOGIC INC

Filing Date Source Excerpt
2018-01-26 Mr. Dockendorff holds a bachelor’s degree in accounting from the University of Massachusetts at Amherst and a Master of Science in finance from Bentley College.
2019-01-18 Mr. Dockendorff holds a bachelor’s degree in accounting from the University of Massachusetts at Amherst and a Master of Science in finance from Bentley College.
2020-01-22 Mr. Dockendorff holds a bachelor’s degree in accounting from the University of Massachusetts at Amherst and a Master of Science in finance from Bentley College.
2021-01-21 Mr. Dockendorff holds a bachelor’s degree in accounting from the University of Massachusetts at Amherst and a Master of Science in finance from Bentley College.
2022-01-20 Mr. Dockendorff has extensive experience with financial accounting matters for complex global healthcare organizations as well as substantial experience overseeing the financial reporting processes of large public companies.
2023-01-19 Mr. Dockendorff holds a bachelor’s degree in accounting from the University of Massachusetts at Amherst and a Master of Science in finance from Bentley College.
2024-01-18 Mr. Dockendorff has extensive experience with financial accounting matters for complex global healthcare organizations as well as substantial experience overseeing the financial reporting processes of large public companies.
2025-01-16 Mr. Dockendorff holds a bachelor’s degree in accounting from the University of Massachusetts at Amherst and a Master of Science in finance from Bentley College.

Data sourced from SEC filings. Last updated: 2025-08-30